Decreased platelet vesicular monoamine transporter density in habitual smokers

European Neuropsychopharmacology

Volumn 15, Issue 2, 2005, Pages 235-238

  Schwartz, Karin ^a   Weizman, Abraham ^a,b   Rehavi, Moshe ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b GEHA MENTAL HEALTH CENTER   (Israel)

Author keywords

Dihydrotetrabenazine (TBZOH); Nicotine; Platelet; Smoking; Vesicular monoamine transporter (VMAT2)

Indexed keywords

DIHYDROTETRABENAZINE; NICOTINE; TRITIUM; VESICULAR MONOAMINE TRANSPORTER 2;

ADULT; AGE; ARTICLE; BINDING AFFINITY; BINDING SITE; CELL DENSITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DESENSITIZATION; DRUG DEPENDENCE; FEMALE; HABIT; HUMAN; HYDROGEN BOND; MALE; OBSERVATION; PRIORITY JOURNAL; SEX; SMOKING; THROMBOCYTE;

EID: 13244277556     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2004.11.001     Document Type: Article

References (18)

1. D.J. Balfour The neurobiology of tobacco dependence: a commentary Respiration 69 2002 7 11
2. D.J. Balfour, and D.L. Ridley The effects of nicotine on neural pathways implicated in depression: a factor in nicotine addiction? Pharmacol. Biochem. Behav. 66 2000 79 85
3. I. Berlin, and R.M. Anthenelli Monoamine oxidases and tobacco smoking Int. J. Neuropsychopharmacol. 4 2001 33 42
4. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
5. G. Di Chiara Role of dopamine in the behavioural actions of nicotine related to addiction Eur. J. Pharmacol. 393 2000 295 314
6. G. Di Chiara, and A. Imperato Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats Proc. Natl. Acad. Sci. U. S. A. 85 1988 5274 5278
7. T.F. Heatherton, L.T. Kozlowski, R.C. Frecker, and K.O. Fagerstrom The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire Br. J. Addict. 86 1991 1119 1127
8. K.M. Malone, C. Waternaux, G.L. Haas, T.B. Cooper, S. Li, and J.J. Mann Cigarette smoking, suicidal behavior, and serotonin function in major psychiatric disorders Am. J. Psychiatry 160 2003 773 779
9. A.A. Patkar, R. Gopalakrishnan, W.H. Berrettini, S.P. Weinstein, M.J. Vergare, and F.T. Leone Differences in platelet serotonin transporter sites between African-American tobacco smokers and non-smokers Psychopharmacology (Berl) 166 2003 221 227
10. S.L. Pfueller, P. Burns, K. Mak, and B.G. Firkin Effects of nicotine on platelet function Haemostasis 18 1988 163 169
11. M. Rehavi, N. Roz, and A. Weizman Chronic clozapine, but not haloperidol, treatment affects rat brain vesicular monoamine transporter 2 Eur. Neuropsychopharmacol. 12 2002 261 268
12. 3H]5- hydroxytryptamine release from rat striatal synaptosomes Neuropharmacology 39 2000 290 299
13. S. Semenova, and A. Markou Clozapine treatment attenuated somatic and affective signs of nicotine and amphetamine withdrawal in subsets of rats exhibiting hyposensitivity to the initial effects of clozapine Biol. Psychiatry 54 2003 1249 1264
14. P. Seth, S. Cheeta, S. Tucci, and S.E. File Nicotinic-serotonergic interactions in brain and behaviour Pharmacol. Biochem. Behav. 71 2002 795 805
15. E.A. Stein, J. Pankiewicz, H.H. Harsch, J.K. Cho, S.A. Fuller, R.G. Hoffmann, M. Hawkins, S.M. Rao, P.A. Bandettini, and A.S. Bloom Nicotine-induced limbic cortical activation in the human brain: a functional MRI study Am. J. Psychiatry 155 1998 1009 1015
16. 3H]TBZOH binding to the human platelet vesicular monoamine transporter Life Sci. 69 2001 2311 2317
17. M. Zucker, A. Aviv, A. Shelef, A. Weizman, and M. Rehavi Elevated platelet vesicular monoamine transporter density in untreated patients diagnosed with major depression Psychiatry Res. 112 2002 251 256
18. M. Zucker, A. Valevski, A. Weizman, and M. Rehavi Increased platelet vesicular monoamine transporter density in adult schizophrenia patients Eur. Neuropsychopharmacol. 12 2002 343 347